DE69505095D1 - Natriumhyaluronat enthaltende viskose Lösungen zur Verwendung als Maskierungsmittel in therapeutischer Photokeratektomie durch Excimer-Laser - Google Patents

Natriumhyaluronat enthaltende viskose Lösungen zur Verwendung als Maskierungsmittel in therapeutischer Photokeratektomie durch Excimer-Laser

Info

Publication number
DE69505095D1
DE69505095D1 DE69505095T DE69505095T DE69505095D1 DE 69505095 D1 DE69505095 D1 DE 69505095D1 DE 69505095 T DE69505095 T DE 69505095T DE 69505095 T DE69505095 T DE 69505095T DE 69505095 D1 DE69505095 D1 DE 69505095D1
Authority
DE
Germany
Prior art keywords
excimer laser
sodium hyaluronate
solutions containing
containing sodium
masking agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69505095T
Other languages
English (en)
Other versions
DE69505095T2 (de
Inventor
Amalio Cantoro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemedica SA
Original Assignee
Chemedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11402853&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69505095(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chemedica SA filed Critical Chemedica SA
Application granted granted Critical
Publication of DE69505095D1 publication Critical patent/DE69505095D1/de
Publication of DE69505095T2 publication Critical patent/DE69505095T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
DE69505095T 1994-12-09 1995-12-04 Natriumhyaluronat enthaltende viskose Lösungen zur Verwendung als Maskierungsmittel in therapeutischer Photokeratektomie durch Excimer-Laser Expired - Lifetime DE69505095T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940797A IT1274984B (it) 1994-12-09 1994-12-09 Soluzioni viscosizzate con ialuronato di sodio per l'uso come fluido maschera nella fotocheratectomia terapeutica mediante laser a accimeri

Publications (2)

Publication Number Publication Date
DE69505095D1 true DE69505095D1 (de) 1998-11-05
DE69505095T2 DE69505095T2 (de) 1999-04-15

Family

ID=11402853

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69505095T Expired - Lifetime DE69505095T2 (de) 1994-12-09 1995-12-04 Natriumhyaluronat enthaltende viskose Lösungen zur Verwendung als Maskierungsmittel in therapeutischer Photokeratektomie durch Excimer-Laser

Country Status (10)

Country Link
US (1) US5871772A (de)
EP (1) EP0719559B1 (de)
JP (1) JP4097720B2 (de)
AT (1) ATE171623T1 (de)
CA (1) CA2164770C (de)
DE (1) DE69505095T2 (de)
DK (1) DK0719559T3 (de)
ES (1) ES2124486T3 (de)
IT (1) IT1274984B (de)
ZA (1) ZA9510441B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291291B1 (it) * 1997-04-30 1999-01-07 Chemedica Sa Uso di acido ialuronico e relativi sali per la preparazione di una soluzione acquosa utile come liquido di lavaggio intra-articolare
AU2002230504A1 (en) * 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic irrigating solution adapted for use in lasik surgery
AU2002232437A1 (en) * 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
EP1256360A1 (de) * 2001-05-10 2002-11-13 Université de Liège Hypertonisches Medikament insbesondere zur Verwendung in der Flüssigkeitstherapie
CN103638040A (zh) * 2002-07-03 2014-03-19 派瑞克科学公司 透明质酸组合物以及使用方法
ATE452659T1 (de) * 2004-10-01 2010-01-15 Menicon Co Ltd Verfahren zur sterilisation verpackter kontaktlinsen mit verpackungslösung
WO2009036098A2 (en) * 2007-09-10 2009-03-19 Lensx Lasers, Inc. Apparatus, systems and techniques for interfacing with an eye in laser surgery
US8845624B2 (en) * 2010-06-25 2014-09-30 Alcon LexSx, Inc. Adaptive patient interface
US9089401B2 (en) 2011-05-06 2015-07-28 Alcon Lensx, Inc. Adjusting ophthalmic docking system
US8939967B2 (en) 2011-08-03 2015-01-27 Alcon Lensx, Inc. Patient interface defogger
US9044304B2 (en) 2011-12-23 2015-06-02 Alcon Lensx, Inc. Patient interface with variable applanation
US10335315B2 (en) 2013-02-01 2019-07-02 Alcon Lensx, Inc. Bi-radial patient interface

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
EP0346467A4 (en) * 1987-12-26 1990-11-28 Kyowa Hakko Kogyo Co., Ltd. Process for purifying hyaluronic acid
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5492135A (en) * 1992-09-09 1996-02-20 Devore; Dale P. Collagen modulators for use in photoablation excimer laser keratectomy

Also Published As

Publication number Publication date
JP4097720B2 (ja) 2008-06-11
ES2124486T3 (es) 1999-02-01
ITRM940797A0 (it) 1994-12-09
DK0719559T3 (da) 1999-06-21
US5871772A (en) 1999-02-16
CA2164770C (en) 2008-04-22
CA2164770A1 (en) 1996-06-10
ITRM940797A1 (it) 1996-06-09
JPH08253505A (ja) 1996-10-01
ATE171623T1 (de) 1998-10-15
EP0719559B1 (de) 1998-09-30
ZA9510441B (en) 1996-06-19
DE69505095T2 (de) 1999-04-15
IT1274984B (it) 1997-07-29
EP0719559A1 (de) 1996-07-03

Similar Documents

Publication Publication Date Title
DE69505095T2 (de) Natriumhyaluronat enthaltende viskose Lösungen zur Verwendung als Maskierungsmittel in therapeutischer Photokeratektomie durch Excimer-Laser
DE69531912D1 (de) Vorrichtung zur chirurgischen Behandlung von Presbyopie
DE69513902T2 (de) Augenpräparat zur Verwendung in künstlicher Tränenflüssigkeit
NO994485L (no) Styrt frigivelse av farmasöytiske midler i det fremre kammer i öyet
BR0212867A (pt) Emulsão de água-em-óleo, composição, e, métodos para umectar pele de mamìfero, para desinfetar tecido de mamìfero e para suprir um agente farmacêutico a um mamìfero
ATE272987T1 (de) Gerät zur behandlung von wachsenden, erweiterten oder missgebildeten blutgefässen
DE69521620T2 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
BR0215218A (pt) Composição aquosa lìquida, método para a preparação da mesma, uso de uma composição, e, métodos para a inibição da coagulação do sangue em um indivìduo, e inibição de reações mediadas pelo fator de tecido em um indivìduo
NO970805L (no) Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme
DE69930271D1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE179888T1 (de) Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
DE69821655D1 (de) Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen
DE60032594D1 (de) Verwendung von pirenoxin zum schutz des kornealgewebes während photokeratektomie
BR9907715A (pt) Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
EA199900830A1 (ru) Терапевтическая минераловитаминная ассоциация в форме унитарного жидкого препарата для питья
Merkx et al. Effectiveness of primary correction of traumatic telecanthus
DE69811758T2 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
ES2168226B1 (es) Composicion que comprende sodio, potasio, calcio y magnesio.
Paulsen et al. Titanium tetrachloride: an unusual agent with the potential to create severe burns
Goodman The rotating burr in rhinoplasty
ES2038663T3 (es) Un metodo para preparar una composicion para la aplicacion por via topica, destinada al tratamiento de la enfermedad epitelial hiperproliferativa.
FR2661091B1 (fr) Utilisation de l'hexetidine ou de ses derives ou sels pour la preparation d'une composition pharmaceutique a usage ophtalmologique.
ATA196398A (de) Corneale maske zur laserchirurgischen abtragung von hornhautgewebe
BRPI0514954A (pt) método para matar ou inativar microorganismos no tecido de mamìfero, composição antimicrobiana, e, métodos para descolonizar pelo menos uma porção das cavidades nasais, das narinas anteriores, e/ou da nasofaringe de um indivìduo, para descolonizar pelo menos uma porção da cavidade do esÈfago de um indivìduo, para tratar uma infecção de ouvido médio em um indivìduo, para tratar sinusite crÈnica em um indivìduo, para tratar e/ou prevenir uma infecção na pele, no tecido mucosal e/ou na ferida de um indivìduo, para fazer uma composição antimicrobiana

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: SEITZ, R., DIPL.-ING.UNIV., PAT.-ANW., 80538 MUENC